Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership1,330 shares
Latest Disclosed Value $ 188,634
Group One Trading, L.p. ownership in NBIX / Neurocrine Biosciences, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 1,330 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $188,634 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2024 disclosing 0 shares of Neurocrine Biosciences, Inc..

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (NBIX) in the form of stock options. The firm currently holds call options representing 3,000 of underlying shares valued at $425,490 USD and put options representing 4,000 of underlying shares valued at $567,320 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:NBIX / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,330 1,330 189 0.0003
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -3,951 -100.00 0 -100.00
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,951 3,951 544 0.0021
2023-08-09 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -12,470 -100.00 0 -100.00
2023-05-12 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 12,470 12,470 1,262 0.0046
2022-11-09 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -2,780 -100.00 0 -100.00
2022-08-11 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,780 -48,709 -94.60 271 -94.39 0.0004
2022-05-12 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 51,489 51,489 4,827 0.0048
2021-05-12 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -222 -100.00 0 -100.00
2021-02-10 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 222 222 21 0.0000
2020-11-12 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -7,201 -100.00 0 -100.00
2020-08-13 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,201 5,809 417.31 879 632.50 0.0041
2020-05-13 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,392 -5,744 -80.49 120 -84.35 0.0010
2020-02-10 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,136 -1,219 -14.59 767 1.86 0.0052
2019-11-12 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,355 3,419 69.27 753 80.58 0.0061
2019-08-09 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,936 2,080 72.83 417 65.48 0.0038
2019-05-14 2019-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 2,856 2,591 977.74 252 1,226.32 0.0028
2019-05-13 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,856 2,591 252
2019-02-05 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 265 -10,895 -97.63 19 -98.62 0.0002
2018-11-08 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,160 11,160 1,372 0.0108
2018-05-16 2018-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 0 -16,092 -100.00 0 -100.00
2018-02-09 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,092 -2,352 -12.75 1,249 10.53 0.0088
2017-11-15 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,444 17,912 3,366.92 1,130 4,608.33 0.0103
2017-08-14 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 532 532 24 0.0002
2016-08-12 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -17,559 -100.00 0 -100.00
2016-05-12 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,559 17,559 0.00 694 0.0098
2016-02-11 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -24,355 -100.00 0 -100.00
2015-11-20 2015-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 24,355 16,209 198.98 969 149.10 0.0134
2015-11-06 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 24,355 969
2015-08-11 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,146 5,426 199.49 389 260.19 0.0054
2015-05-14 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,720 2,720 0.00 108 0.0017
2015-02-11 2014-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -37,503 -100.00 0 -100.00
2014-10-31 2014-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 37,503 25,595 214.94 588 429.73 0.0091
2014-01-31 2013-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,908 -15,462 -56.49 111 -64.19 0.0017
2013-11-15 2013-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 27,370 21,672 380.34 310 307.89 0.0059
2013-08-02 2013-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,698 5,698 76 0.0019
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F NEUROCRINE BIOSCIENCES COM Call 3,000 76.47 425 78.57 n/a n/a n/a
2025-11-12 2025-09-30 13F NEUROCRINE BIOSCIENCES COM Call 1,700 -66.67 239 -62.87 n/a n/a n/a
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM Call 5,100 -75.60 641 -72.26 n/a n/a n/a
2025-05-14 2025-03-31 13F NEUROCRINE BIOSCIENCES COM Call 20,900 287.04 2,312 213.57 n/a n/a n/a
2025-05-14 2024-12-31 13F/A NEUROCRINE BIOSCIENCES COM Call 5,400 -32.50 737 -19.98 n/a n/a n/a
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM Call 5,400 737 n/a n/a n/a
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM Call 8,000 -6.98 922 -22.15 n/a n/a n/a
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM Call 8,600 -80.05 1,184 -80.10 n/a n/a n/a
2024-05-10 2024-03-31 13F NEUROCRINE BIOSCIENCES COM Call 43,100 93.27 5,944 102.31 n/a n/a n/a
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM Call 22,300 -37.88 2,938 -27.24 n/a n/a n/a
2023-11-09 2023-09-30 13F NEUROCRINE BIOSCIENCES COM Call 35,900 14.70 4,039 36.83 n/a n/a n/a
2023-08-09 2023-06-30 13F NEUROCRINE BIOSCIENCES COM Call 31,300 10.60 2,952 3.04 n/a n/a n/a
2023-05-12 2023-03-31 13F NEUROCRINE BIOSCIENCES COM Call 28,300 -71.61 2,865 -75.95 n/a n/a n/a
2023-02-09 2022-12-31 13F NEUROCRINE BIOSCIENCES COM Call 99,700 359.45 11,908 416.62 n/a n/a n/a
2022-11-09 2022-09-30 13F NEUROCRINE BIOSCIENCES COM Call 21,700 -41.19 2,305 -35.92 n/a n/a n/a
2022-08-11 2022-06-30 13F NEUROCRINE BIOSCIENCES COM Call 36,900 26.37 3,597 31.37 n/a n/a n/a
2022-05-12 2022-03-31 13F NEUROCRINE BIOSCIENCES COM Call 29,200 2.46 2,738 12.81 n/a n/a n/a
2022-02-11 2021-12-31 13F NEUROCRINE BIOSCIENCES COM Call 28,500 143.59 2,427 116.31 n/a n/a n/a
2021-11-12 2021-09-30 13F NEUROCRINE BIOSCIENCES COM Call 11,700 -62.38 1,122 -62.93 n/a n/a n/a
2021-08-10 2021-06-30 13F NEUROCRINE BIOSCIENCES COM Call 31,100 -38.54 3,027 -38.49 n/a n/a n/a
2021-05-12 2021-03-31 13F NEUROCRINE BIOSCIENCES COM Call 50,600 61.66 4,921 64.03 n/a n/a n/a
2021-02-10 2020-12-31 13F NEUROCRINE BIOSCIENCES COM Call 31,300 125.18 3,000 124.38 n/a n/a n/a
2020-11-12 2020-09-30 13F NEUROCRINE BIOSCIENCES COM Call 13,900 172.55 1,337 114.95 n/a n/a n/a
2020-08-13 2020-06-30 13F NEUROCRINE BIOSCIENCES COM Call 5,100 -72.58 622 -61.37 n/a n/a n/a
2020-05-13 2020-03-31 13F NEUROCRINE BIOSCIENCES COM Call 18,600 -51.44 1,610 -60.89 n/a n/a n/a
2020-02-10 2019-12-31 13F NEUROCRINE BIOSCIENCES COM Call 38,300 447.14 4,117 552.46 n/a n/a n/a
2019-11-12 2019-09-30 13F NEUROCRINE BIOSCIENCES COM Call 7,000 84.21 631 96.57 n/a n/a n/a
2019-08-09 2019-06-30 13F NEUROCRINE BIOSCIENCES COM Call 3,800 -55.81 321 -57.65 n/a n/a n/a
2019-05-14 2019-03-31 13F/A NEUROCRINE BIOSCIENCES COM Call 8,600 -31.20 758 -15.12 n/a n/a n/a
2019-05-13 2019-03-31 13F NEUROCRINE BIOSCIENCES COM Call 8,600 758 n/a n/a n/a
2019-02-05 2018-12-31 13F NEUROCRINE BIOSCIENCES COM Call 12,500 941.67 893 503.38 n/a n/a n/a
2018-11-08 2018-09-30 13F NEUROCRINE BIOSCIENCES COM Call 1,200 -98.08 148 -97.59 n/a n/a n/a
2018-08-13 2018-06-30 13F NEUROCRINE BIOSCIENCES COM Call 62,500 120.85 6,140 161.61 n/a n/a n/a
2018-05-16 2018-03-31 13F/A NEUROCRINE BIOSCIENCES COM Call 28,300 41.50 2,347 51.22 n/a n/a n/a
2018-05-10 2018-03-31 13F NEUROCRINE BIOSCIENCES COM Call 28,300 2,347 n/a n/a n/a
2018-02-09 2017-12-31 13F NEUROCRINE BIOSCIENCES COM Call 20,000 1,566.67 1,552 1,997.30 n/a n/a n/a
2017-11-15 2017-09-30 13F NEUROCRINE BIOSCIENCES COM Call 1,200 -96.35 74 -95.11 n/a n/a n/a
2017-08-14 2017-06-30 13F NEUROCRINE BIOSCIENCES COM Call 32,900 46.88 1,513 55.98 n/a n/a n/a
2017-05-10 2017-03-31 13F NEUROCRINE BIOSCIENCES COM Call 22,400 17.28 970 31.26 n/a n/a n/a
2017-02-15 2016-12-31 13F NEUROCRINE BIOSCIENCES COM Call 19,100 -86.07 739 -89.36 n/a n/a n/a
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COM Call 137,100 -15.63 6,943 -6.00 n/a n/a n/a
2016-08-12 2016-06-30 13F NEUROCRINE BIOSCIENCES COM Call 162,500 447.14 7,386 528.60 n/a n/a n/a
2016-05-12 2016-03-31 13F NEUROCRINE BIOSCIENCES COM Call 29,700 -57.75 1,175 -70.46 n/a n/a n/a
2016-02-11 2015-12-31 13F NEUROCRINE BIOSCIENCES COM Call 70,300 -15.71 3,977 19.86 n/a n/a n/a
2015-11-20 2015-09-30 13F/A NEUROCRINE BIOSCIENCES COM Call 83,400 44.04 3,318 20.00 n/a n/a n/a
2015-11-06 2015-09-30 13F NEUROCRINE BIOSCIENCES COM Call 83,400 3,318 n/a n/a n/a
2015-08-11 2015-06-30 13F NEUROCRINE BIOSCIENCES COM Call 57,900 -15.97 2,765 1.06 n/a n/a n/a
2015-05-14 2015-03-31 13F NEUROCRINE BIOSCIENCES COM Call 68,900 -29.91 2,736 24.59 n/a n/a n/a
2015-02-11 2014-12-31 13F NEUROCRINE BIOSCIENCES COM Call 98,300 123.92 2,196 219.19 n/a n/a n/a
2014-10-31 2014-09-30 13F NEUROCRINE BIOSCIENCES COM Call 43,900 -46.66 688 -43.65 n/a n/a n/a
2014-08-12 2014-06-30 13F NEUROCRINE BIOSCIENCES COM Call 82,300 120.05 1,221 102.82 n/a n/a n/a
2014-05-07 2014-03-31 13F NEUROCRINE BIOSCIENCES COM Call 37,400 5.95 602 82.42 n/a n/a n/a
2014-01-31 2013-12-31 13F NEUROCRINE BIOSCIENCES COM Call 35,300 -32.12 330 -43.97 n/a n/a n/a
2013-11-15 2013-09-30 13F NEUROCRINE BIOSCIENCES COM Call 52,000 -24.31 589 -35.91 n/a n/a n/a
2013-08-02 2013-06-30 13F NEUROCRINE BIOSCIENCES COM Call 68,700 919 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F NEUROCRINE BIOSCIENCES COM Put 4,000 3,900.00 567 3,950.00 n/a n/a n/a
2025-11-12 2025-09-30 13F NEUROCRINE BIOSCIENCES COM Put 100 -92.86 14 -92.00 n/a n/a n/a
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM Put 1,400 -68.89 176 -64.79 n/a n/a n/a
2025-05-14 2025-03-31 13F NEUROCRINE BIOSCIENCES COM Put 4,500 498 n/a n/a n/a
2025-05-14 2024-12-31 13F/A NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM Put 0 0 n/a n/a n/a
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM Put 11,300 -33.14 1,302 -44.07 n/a n/a n/a
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM Put 16,900 62.50 2,327 62.20 n/a n/a n/a
2024-05-10 2024-03-31 13F NEUROCRINE BIOSCIENCES COM Put 10,400 4.00 1,434 8.88 n/a n/a n/a
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM Put 10,000 -9.09 1,318 6.47 n/a n/a n/a
2023-11-09 2023-09-30 13F NEUROCRINE BIOSCIENCES COM Put 11,000 182.05 1,238 237.06 n/a n/a n/a
2023-08-09 2023-06-30 13F NEUROCRINE BIOSCIENCES COM Put 3,900 -82.82 368 -84.02 n/a n/a n/a
2023-05-12 2023-03-31 13F NEUROCRINE BIOSCIENCES COM Put 22,700 2,298 n/a n/a n/a
2023-02-09 2022-12-31 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-09 2022-09-30 13F NEUROCRINE BIOSCIENCES COM Put 25,800 -32.46 2,740 -26.42 n/a n/a n/a
2022-08-11 2022-06-30 13F NEUROCRINE BIOSCIENCES COM Put 38,200 -61.99 3,724 -60.48 n/a n/a n/a
2022-05-12 2022-03-31 13F NEUROCRINE BIOSCIENCES COM Put 100,500 325.85 9,422 368.76 n/a n/a n/a
2022-02-11 2021-12-31 13F NEUROCRINE BIOSCIENCES COM Put 23,600 353.85 2,010 302.81 n/a n/a n/a
2021-11-12 2021-09-30 13F NEUROCRINE BIOSCIENCES COM Put 5,200 -76.15 499 -76.48 n/a n/a n/a
2021-08-10 2021-06-30 13F NEUROCRINE BIOSCIENCES COM Put 21,800 251.61 2,122 251.91 n/a n/a n/a
2021-05-12 2021-03-31 13F NEUROCRINE BIOSCIENCES COM Put 6,200 -83.55 603 -83.31 n/a n/a n/a
2021-02-10 2020-12-31 13F NEUROCRINE BIOSCIENCES COM Put 37,700 323.60 3,614 322.20 n/a n/a n/a
2020-11-12 2020-09-30 13F NEUROCRINE BIOSCIENCES COM Put 8,900 2.30 856 -19.32 n/a n/a n/a
2020-08-13 2020-06-30 13F NEUROCRINE BIOSCIENCES COM Put 8,700 -13.86 1,061 21.40 n/a n/a n/a
2020-05-13 2020-03-31 13F NEUROCRINE BIOSCIENCES COM Put 10,100 -80.23 874 -84.09 n/a n/a n/a
2020-02-10 2019-12-31 13F NEUROCRINE BIOSCIENCES COM Put 51,100 177.72 5,493 231.30 n/a n/a n/a
2019-11-12 2019-09-30 13F NEUROCRINE BIOSCIENCES COM Put 18,400 155.56 1,658 172.70 n/a n/a n/a
2019-08-09 2019-06-30 13F NEUROCRINE BIOSCIENCES COM Put 7,200 148.28 608 138.43 n/a n/a n/a
2019-05-14 2019-03-31 13F/A NEUROCRINE BIOSCIENCES COM Put 2,900 -56.06 255 -45.86 n/a n/a n/a
2019-05-13 2019-03-31 13F NEUROCRINE BIOSCIENCES COM Put 2,900 255 n/a n/a n/a
2019-02-05 2018-12-31 13F NEUROCRINE BIOSCIENCES COM Put 6,600 120.00 471 27.64 n/a n/a n/a
2018-11-08 2018-09-30 13F NEUROCRINE BIOSCIENCES COM Put 3,000 -89.58 369 -86.96 n/a n/a n/a
2018-08-13 2018-06-30 13F NEUROCRINE BIOSCIENCES COM Put 28,800 13.39 2,829 34.33 n/a n/a n/a
2018-05-16 2018-03-31 13F/A NEUROCRINE BIOSCIENCES COM Put 25,400 -52.08 2,106 -48.78 n/a n/a n/a
2018-05-10 2018-03-31 13F NEUROCRINE BIOSCIENCES COM Put 25,400 2,106 n/a n/a n/a
2018-02-09 2017-12-31 13F NEUROCRINE BIOSCIENCES COM Put 53,000 3,685.71 4,112 4,681.40 n/a n/a n/a
2017-11-15 2017-09-30 13F NEUROCRINE BIOSCIENCES COM Put 1,400 -82.93 86 -77.19 n/a n/a n/a
2017-08-14 2017-06-30 13F NEUROCRINE BIOSCIENCES COM Put 8,200 -21.90 377 -17.14 n/a n/a n/a
2017-05-10 2017-03-31 13F NEUROCRINE BIOSCIENCES COM Put 10,500 -81.35 455 -79.12 n/a n/a n/a
2017-02-15 2016-12-31 13F NEUROCRINE BIOSCIENCES COM Put 56,300 63.66 2,179 25.09 n/a n/a n/a
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COM Put 34,400 -0.86 1,742 10.46 n/a n/a n/a
2016-08-12 2016-06-30 13F NEUROCRINE BIOSCIENCES COM Put 34,700 10.51 1,577 26.97 n/a n/a n/a
2016-05-12 2016-03-31 13F NEUROCRINE BIOSCIENCES COM Put 31,400 -48.18 1,242 -63.77 n/a n/a n/a
2016-02-11 2015-12-31 13F NEUROCRINE BIOSCIENCES COM Put 60,600 -33.84 3,428 -5.95 n/a n/a n/a
2015-11-20 2015-09-30 13F/A NEUROCRINE BIOSCIENCES COM Put 91,600 87.32 3,645 56.10 n/a n/a n/a
2015-11-06 2015-09-30 13F NEUROCRINE BIOSCIENCES COM Put 91,600 3,645 n/a n/a n/a
2015-08-11 2015-06-30 13F NEUROCRINE BIOSCIENCES COM Put 48,900 -44.87 2,335 -33.70 n/a n/a n/a
2015-05-14 2015-03-31 13F NEUROCRINE BIOSCIENCES COM Put 88,700 -31.19 3,522 22.29 n/a n/a n/a
2015-02-11 2014-12-31 13F NEUROCRINE BIOSCIENCES COM Put 128,900 109.59 2,880 198.76 n/a n/a n/a
2014-10-31 2014-09-30 13F NEUROCRINE BIOSCIENCES COM Put 61,500 28.93 964 36.16 n/a n/a n/a
2014-08-12 2014-06-30 13F NEUROCRINE BIOSCIENCES COM Put 47,700 278.57 708 248.77 n/a n/a n/a
2014-05-07 2014-03-31 13F NEUROCRINE BIOSCIENCES COM Put 12,600 -34.38 203 13.41 n/a n/a n/a
2014-01-31 2013-12-31 13F NEUROCRINE BIOSCIENCES COM Put 19,200 -83.08 179 -86.07 n/a n/a n/a
2013-11-15 2013-09-30 13F NEUROCRINE BIOSCIENCES COM Put 113,500 233.82 1,285 182.42 n/a n/a n/a
2013-08-02 2013-06-30 13F NEUROCRINE BIOSCIENCES COM Put 34,000 455 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.